GlassScriptPhysician profile
Jacqueline Babayev
NPI 1023571452
$5,243.49
in general payments reported to CMS, 2019-2025
10 companies · $3,854 in 2025
The $3,854 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $654 · 2024: $735 · 2025: $3,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,023 · Travel and Lodging: $1,801 · Education: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,022.63 |
| Travel and Lodging | $1,800.87 |
| Education | $419.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,655.05 | 2023-2025 | Augment Injectable, Allowrap, Variax |
| Arthrex, INC. | $1,297.25 | 2025 | |
| Suvon Surgical LLC | $1,008.21 | 2025 | |
| Medical Device Business Services, INC. | $419.99 | 2023 | |
| Aroa Biosurgery Incorporated | $273.85 | 2024 | |
| Kerecis Limited | $154.65 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $150.65 | 2025 | |
| Paragon 28, INC. | $143.92 | 2025 | Precision Mis Bunion |
| Paratek Pharmaceuticals, INC. | $121.24 | 2025 | Nuzyra |
| Abbvie INC. | $18.68 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Babayev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.